Le Lézard
Classified in: Health

2018 $6.5 Bn Surgical Site Infection Control Market - Global Forecast to 2026


DUBLIN, Jan. 18, 2019 /PRNewswire/ --

The "Surgical Site Infection Control - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global Surgical Site Infection Control market accounted for $3705.7 million in 2017 and is expected to reach $6,519.9 million by 2026 growing at a CAGR of 6.5%

Factors such as rising number of surgeries, increase in hospital acquired infection and rapidly increasing geriatric population are fueling the market growth. However, rise in use of outpatient treatment and lack of awareness of hospital infection prevention and control are hampering the market growth.

Based on type, Superficial Incisional Surgical Site Infection (SSI) segment has witnessed the significant market growth during the forecast period. Due to it occurs only in the area of the skin where the incision was made within 30 days after the operation. By Geography, North America accounts for the largest market share during the forecast period. The growth can be attributed to the rising geriatric population and growing demand for non-invasive aesthetic procedures are driving the market in this region.

Key Topics Covered:

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.5 Research Sources

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 End User Analysis

3.8 Emerging Markets

3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Surgical Site Infection Control Market, By Type of Infection

5.1 Introduction

5.2 Deep Incisional Surgical Site Infection (SSI)

5.3 Organ or Space Surgical Site Infection (SSI)

5.4 Superficial Incisional Surgical Site Infection (SSI)

6 Global Surgical Site Infection Control Market, By Procedure

6.1 Introduction

6.2 Cesarean Section

6.3 Gastric Bypass

6.4 Cataract Surgery

6.5 Dental Restoration

6.6 Other Procedures

7 Global Surgical Site Infection Control Market, By Product

7.1 Introduction

7.2 Surgical Scrubs

7.3 Surgical Irrigation

7.4 Hair Clippers

7.5 Skin Preparation Solution

7.6 Surgical Gloves

7.7 Medical Nonwovens

7.8 Surgical Drapes

7.9 Manual Reprocessors Solution

7.10 Disinfectants

7.10.1 Skin Disinfectants

7.10.2 Hand Disinfectants

7.11 Other Products

8 Global Surgical Site Infection Control Market, By End User

8.1 Introduction

8.2 Ambulatory Surgical Centers

8.3 Hospitals

9 Global Surgical Site Infection Control Market, By Geography

9.1 Introduction

9.2 North America

9.3 Europe

9.4 Asia Pacific

9.5 South America

9.6 Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures

10.2 Acquisitions & Mergers

10.3 New Product Launch

10.4 Expansions

10.5 Other Key Strategies

11 Company Profiling

11.1 3M Company

11.2 Johnson & Johnson

11.3 Becton, Dickinson and Company

11.4 Biomerieux SA

11.5 Kimberly-Clark

11.6 Steris Corporation

11.7 Pacon Manufacturing Corp.

11.8 American Polyfilm Inc

11.9 Ansell Limited

11.10 Lac-Mac Limited

11.11 Belimed AG

11.12 Getinge Group

For more information about this report visit

https://www.researchandmarkets.com/research/k68gg4/2018_6_5_bn?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 03:05
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease...

at 03:00
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay...

at 03:00
Viewpoint, the esteemed educational program hosted by distinguished actor Dennis Quaid, is pleased to announce a collaborative effort with Medical Aid International for an upcoming episode dedicated to transforming healthcare in Low and Middle Income...

at 02:35
SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated to the development of monoclonal antibodies to prevent viral infections in immunocompromised patients, today...

at 02:00
SSI Schaefer, a global leader in warehouse automation and cold-chain storage solutions, is announcing the results of its partnership with Noatum Logistics Middle East, an integrated regional end-to-end logistics services arm of Noatum, an AD...

at 01:48
The consignment of sulfuric acid originated from Young Poong's Seokpo Smelter adds to the operational risks for Korea Zinc Young Poong has passed the costs and risks associated with sulfuric acid management to Korea Zinc while backlash from the local...



News published on and distributed by: